1. Home
  2. SVII vs PROF Comparison

SVII vs PROF Comparison

Compare SVII & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVII
  • PROF
  • Stock Information
  • Founded
  • SVII 2021
  • PROF N/A
  • Country
  • SVII United States
  • PROF Canada
  • Employees
  • SVII N/A
  • PROF N/A
  • Industry
  • SVII Blank Checks
  • PROF Medical/Dental Instruments
  • Sector
  • SVII Finance
  • PROF Health Care
  • Exchange
  • SVII Nasdaq
  • PROF Nasdaq
  • Market Cap
  • SVII 119.4M
  • PROF 130.4M
  • IPO Year
  • SVII 2022
  • PROF N/A
  • Fundamental
  • Price
  • SVII $14.11
  • PROF $5.56
  • Analyst Decision
  • SVII
  • PROF Strong Buy
  • Analyst Count
  • SVII 0
  • PROF 1
  • Target Price
  • SVII N/A
  • PROF $11.00
  • AVG Volume (30 Days)
  • SVII 150.0K
  • PROF 171.7K
  • Earning Date
  • SVII 01-01-0001
  • PROF 11-13-2025
  • Dividend Yield
  • SVII N/A
  • PROF N/A
  • EPS Growth
  • SVII N/A
  • PROF N/A
  • EPS
  • SVII 0.17
  • PROF N/A
  • Revenue
  • SVII N/A
  • PROF $11,840,000.00
  • Revenue This Year
  • SVII N/A
  • PROF $60.07
  • Revenue Next Year
  • SVII N/A
  • PROF $121.80
  • P/E Ratio
  • SVII $85.61
  • PROF N/A
  • Revenue Growth
  • SVII N/A
  • PROF 59.81
  • 52 Week Low
  • SVII $11.20
  • PROF $3.76
  • 52 Week High
  • SVII $14.80
  • PROF $9.17
  • Technical
  • Relative Strength Index (RSI)
  • SVII 73.82
  • PROF 52.47
  • Support Level
  • SVII $12.18
  • PROF $5.72
  • Resistance Level
  • SVII $14.80
  • PROF $7.17
  • Average True Range (ATR)
  • SVII 0.51
  • PROF 0.44
  • MACD
  • SVII 0.19
  • PROF 0.01
  • Stochastic Oscillator
  • SVII 74.35
  • PROF 30.30

About SVII Spring Valley Acquisition Corp. II

Spring Valley Acquisition Corp II is a blank check company.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: